Home : FDA Drug Database : Acthar : Newsfeeds

Acthar - Newsfeeds

Why Keeping Weight Off Is So Hard: The Brain Changes: There also were chemical changes in the way the mice's bodies regulated the release of another stress hormone, called corticotropin-releasing factor, as well as melanin-concentrating hormone and orexin, hormones thought to control eating behavior.
Just Breathe: Body Has A Built-In Stress Reliever: There are plenty of ways to relieve stress — exercise, a long soak in a hot bath, or even a massage. But believe it or not, something you're doing right now, probably without even thinking about it, is a proven stress reliever: breathing. As it turns out ...
Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies: This report describes the latest concepts of pathomechanisms of pain as a basis for management and development of new pharmacotherapies for pain. Major segments of the pain market are arthritis, neuropathic pain and cancer pain. Because pain is a ...
Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference on Monday,: Questcor markets H.P. Acthar® Gel (repository corticotropin injection), which is indicated for the treatment of acute exacerbations of multiple sclerosis in adults, and as monotherapy for the treatment of IS in infants and children under 2 years of age.
Research roundup: Barriers to trauma care, immunizations; Small business tax credit; Medicare coverage of ...: Archives of Surgery : Possible Geographical Barriers To Trauma Center Access For Vulnerable Patients In The United States - This study analyzes disparities in geographic access to trauma centers in 2005, drawing from data from the 2005 American Hospital ...
A Different Look at Corticosteroids: Glucocorticoids are primarily regulated by corticotropin (ACTH) and can have anti-inflammatory effects, as well as several metabolic and immunogenic effects, on the body. 1 While several corticosteroid agents possess properties of both hormones ...
Addiction Relapse Associated with Temptation Brain Chemical: The chemical is called corticotropin-releasing factor. Action Points Advise patients who ask that this study suggests that the cues that surround an addiction may combine with stress to create an increased desire for the addictive behavior. Note that the ...
Study finds brain chemical linked to grief: Further tests demonstrated that a brain chemical known as "corticotropin releasing factor," a neurotransmitter involved in the stress response, was elevated in all the voles which had bonded with a partner. Voles given a compound which blocks the chemical ...
Questcor Drug Approval Expected Friday: The official U.S. Food and Drug Administration approval decision date for Questcor's Acthar is Saturday, Sept. 11, which means it likely the company will hear from the agency on Friday afternoon, or Monday at the latest. Wednesday, Oppenheimer analyst John ...
Bay Biz Buzz: iPhone sales may be hurt by antenna problems: Apple Inc.'s antenna design for the iPhone 4, the newest smartphone in its lineup, may be holding back sales of the device, according to a Piper Jaffray Cos. report released Wednesday. Cupertino-based Apple may lose up to 20 percent of its potential sales ...

Questcor Updates Status of Supplemental New Drug Application: In conjunction with the FDA's review of this sNDA, Questcor and the FDA have been updating and modernizing the product label for Acthar, which has not been modified since 1978, when multiple sclerosis was added to the label. This step of the review process ...
FDA Approves H.P. Acthar Gel for the Treatment of Infantile Spasms: ANAHEIM, Calif. , Oct. 15 /PRNewswire-FirstCall/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository ...
Questcor to Present at the Maxim Group Growth Conference: ANAHEIM, Calif. , Nov. 16, 2010 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR - News ) announced today that it will present at the Maxim Group Growth Conference at 4:00 p.m. ET on Thursday, November 18, 2010 at the Grand Hyatt Hotel in New ...
Still Has Room To Grow...?: Did you guess that the repository corticotrophin injection is Acthar Gel? And yes, it is Questcor Pharmaceuticals Inc. (QCOR: News ) that markets H.P. Acthar Gel that we are bringing to your radar. Located in San Francisco Bay Area, Questcor is focused on ...
Questcor Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference: is a biopharmaceutical company whose products help patients with serious, difficult-to-treat medical conditions. Questcor markets H.P. Acthar(R) Gel (repository corticotropin injection), which is indicated for the treatment of acute exacerbations of ...
Neurocrine Biosciences Says GSK561679 Fails To Show Treatment Effect In Mid-stage Trial To Treat ...: (RTTNews) - Neurocrine Biosciences Inc. (NBIX: News ) said that its Corticotropin Releasing Factor (CRF1) receptor antagonist, GSK561679, did not demonstrate a treatment effect in a phase II clinical trial when ...
UPDATE 1-Neurocrine's depression drug fails mid-stage trial: a corticotropin releasing factor (CRF1) receptor antagonist called GSK561679. Three separate academic collaborative clinical trials are ongoing to evaluate the effects of GSK561679 in post traumatic stress disorder,
Neurocrine's depression drug fails mid-stage trial: a corticotropin releasing factor (CRF1) receptor antagonist called GSK561679. Three separate academic collaborative clinical trials are ongoing to evaluate the effects of GSK561679 in post traumatic stress disorder,
Cortisol: A Basic Introduction: must produce corticotropin-releasing hormone and antidiuretic hormone. These two hormones instruct the nearby pituitary gland to secrete corticotropin which is also known as adrenocorticotropic hormone or,
Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for ...: Neurocrine Biosciences, Inc. (Nasdaq: NBIX | PowerRating ) today announced top-line efficacy and safety results from a Phase II clinical trial utilizing Corticotropin Releasing Factor (CRF1) receptor ...

Want to contact a District of Columbia Acthar lawyer? ...Get a free case evaluation from one of our District of Columbia Acthar lawyers now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: 1 2 3 4 Next

Need An Acthar Attorney?

First Name Last Name Email Address State

Legal Issue

FDA Drug Database: Acthar Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Acthar Information

Click to View Our Legal Resources

Want to contact a District of Columbia Acthar lawyer? ...Get a free case evaluation from one of our District of Columbia Acthar lawyers now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120521-153906

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

FDA Drug Database: Acthar Click to select a Legal Issue

Close (x)

Find Legal Help for Your Acthar Case - Submit Your Information Below

Do you need legal assistance with your Acthar case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * FDA Drug Database: Acthar Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.